CROI 2021 – Conference on Retroviruses and Opportunistic Infections

The 2021 Conference on Retroviruses and Opportunistic Infections (CROI) will be held March 6-10, 2021 in a virtual format.

The synergy of basic science and clinical investigation has been a major contributor to the success of the meeting. CROI has facilitated the presentation of important discoveries in the field, thereby accelerating progress in HIV and AIDS research. As always, the best and most consequential original research will define the science at virtual CROI 2021 (vCROI 2021), which will include research in HIV, hepatitis viruses, SARS-CoV-2, and other viral infections and their related conditions.

Highlighted sessions include:

• Advances in Molecular Virology of HIV and SARS-CoV-2 – Frank Kirchhoff, Ulm University Medical Center
• Advances in COVID-19 Treatments and Controlling the Epidemic – Jürgen Rockstroh, Medizinische Universitatsklini
• Vaccine Nationalism is Killing Us: How Inequities in Research and Access to SARS-CoV-2 Vaccines Will Perpetuate the Pandemic – Gregg Gonsalves, Yale University, Fatima Hassan, Health Justice Initiative
• Lessons from the Concurrent HIV/AIDS and COVID-19 Pandemics: A Two-Way Street
  Anthony S. Fauci, National Institutes of Health
• SARS-CoV-2–Specific and Cross-Reactive T-Cell Responses – Daniela Weiskopf, La Jolla Institute for Immunology
• Making Sense of Study Design Differences Between COVID-19 Platform Trials – Lori Dodd, National Institutes of Health
• Design of Current and Future COVID-19 Vaccine Efficacy Trials – Holly Janes, Fred Hutchinson Cancer Research Center
• Rapid Genomic Sequencing for Management of COVID-19 – Kwok-Yung Yuen, The University of Hong Kong
• Imaging Viral Life Cycles – Hans-Georg Kräusslich, Heidelberg University
• SARS-CoV-2 Evolution in Populations and Individuals – moderated by Katharine J. Bar, University of Pennsylvania and John Coffin, Tufts University
• Contact Tracing in Controlling Epidemics: Is the Juice Worth the Squeeze? – Moderator: Wafaa El-Sadr, Columbia University
• Origin, Pathogenicity, and Immune Evasion Strategies of Human Coronaviruses – Volker Thiel, University of Bern
• Immune Responses to SARS-CoV-2 – Akiko Iwasaki, Yale University
• The Potential of Long-Acting Injectable Drugs for Prevention and Treatment of Tuberculous – Eric Nuermberger, Johns Hopkins University
• Advances in Pediatric TB Prevention and Treatment – Nicole Salazar-Austin, Johns Hopkins University
• Humoral Responses Against the SARS-CoV-2 Spike – Andrés Finzi, University of Montreal
• T-Cell Immunity in SARS-CoV-2 Natural Infection and Following Vaccination – Julie McElrath
• Longitudinal Antibody Responses to SARS-CoV-2 and Emerging Variants – Katie Doores, King’s College London
• Programming Durable Immunity – Robert Seder, Vaccine Research Center
• Pathological B-Cell activation During SARS-CoV-2 Infection – Ignacio Sanz, Emory University
• Breaking the B-Cell Barrier to Eliminate Viral Reservoirs – Afam Okoye, Oregon Health Sciences University
• Models of Delivering PrEP in East Africa: Innovations and Lessons Learned – Moses Kamya, Makerere University College of Health Sciences
• Got Anything for This Cough? New Antivirals for Treatment of SARS-CoV-2 – Davey Smith, University of California
• Body on Fire: Multisystem Inflammatory Syndrome in Children – Elizabeth Whittaker, Imperial College London
• Think About It: Neurologic Manifestations of COVID-19 – Benedict Michael, University of Liverpool

Live and on-demand sessions from CROI 2021 will be available to registered attendees during the conference. Thereafter, recordings of live and on-demand sessions will be available to nonregistrants only through a paid subscription. For more information, visit the CROI resources page.